ArticleCancers2025

Assessment of Early Cardiotoxicity and Cardiac Dysfunction of Radioligand Therapy in Patients with Neuroendocrine Tumors.

Katarzyna Jóźwik-Plebanek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.